Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Micropore is a private U.S. manufacturing company that develops and commercializes solid-form carbon dioxide absorbent technology for rebreathing and life-support applications. Its products are used across medical, anesthesia, military, diving, submarine, mining, fire-fighting, and emergency-response settings, where reliable CO2 scrubbing is critical. The company markets its absorbent systems under the ExtendAir and SpiraLithCa brands and emphasizes performance advantages over traditional granular absorbents. Micropore operates as a commercial-stage device and materials business rather than a therapeutics developer, with ISO 9001 and ISO 13485 manufacturing capabilities in the United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Micropore.